Global Central Nervous System Therapeutic Market Research Report 2023

Report ID: 1897777 | Published Date: Sep 2024 | No. of Page: 94 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Central Nervous System Therapeutic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 OTC
        1.2.3 Rx Drugs
    1.3 Market by Application
        1.3.1 Global Central Nervous System Therapeutic Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Central Nervous System Therapeutic Market Perspective (2017-2028)
    2.2 Central Nervous System Therapeutic Growth Trends by Region
        2.2.1 Central Nervous System Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Central Nervous System Therapeutic Historic Market Size by Region (2017-2022)
        2.2.3 Central Nervous System Therapeutic Forecasted Market Size by Region (2023-2028)
    2.3 Central Nervous System Therapeutic Market Dynamics
        2.3.1 Central Nervous System Therapeutic Industry Trends
        2.3.2 Central Nervous System Therapeutic Market Drivers
        2.3.3 Central Nervous System Therapeutic Market Challenges
        2.3.4 Central Nervous System Therapeutic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Central Nervous System Therapeutic Players by Revenue
        3.1.1 Global Top Central Nervous System Therapeutic Players by Revenue (2017-2022)
        3.1.2 Global Central Nervous System Therapeutic Revenue Market Share by Players (2017-2022)
    3.2 Global Central Nervous System Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Central Nervous System Therapeutic Revenue
    3.4 Global Central Nervous System Therapeutic Market Concentration Ratio
        3.4.1 Global Central Nervous System Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System Therapeutic Revenue in 2021
    3.5 Central Nervous System Therapeutic Key Players Head office and Area Served
    3.6 Key Players Central Nervous System Therapeutic Product Solution and Service
    3.7 Date of Enter into Central Nervous System Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System Therapeutic Breakdown Data by Type
    4.1 Global Central Nervous System Therapeutic Historic Market Size by Type (2017-2022)
    4.2 Global Central Nervous System Therapeutic Forecasted Market Size by Type (2023-2028)
5 Central Nervous System Therapeutic Breakdown Data by Application
    5.1 Global Central Nervous System Therapeutic Historic Market Size by Application (2017-2022)
    5.2 Global Central Nervous System Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Central Nervous System Therapeutic Market Size (2017-2028)
    6.2 North America Central Nervous System Therapeutic Market Size by Country (2017-2022)
    6.3 North America Central Nervous System Therapeutic Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Central Nervous System Therapeutic Market Size (2017-2028)
    7.2 Europe Central Nervous System Therapeutic Market Size by Country (2017-2022)
    7.3 Europe Central Nervous System Therapeutic Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Central Nervous System Therapeutic Market Size (2017-2028)
    8.2 Asia-Pacific Central Nervous System Therapeutic Market Size by Country (2017-2022)
    8.3 Asia-Pacific Central Nervous System Therapeutic Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Central Nervous System Therapeutic Market Size (2017-2028)
    9.2 Latin America Central Nervous System Therapeutic Market Size by Country (2017-2022)
    9.3 Latin America Central Nervous System Therapeutic Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Central Nervous System Therapeutic Market Size (2017-2028)
    10.2 Middle East & Africa Central Nervous System Therapeutic Market Size by Country (2017-2022)
    10.3 Middle East & Africa Central Nervous System Therapeutic Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Biogen
        11.1.1 Biogen Company Detail
        11.1.2 Biogen Business Overview
        11.1.3 Biogen Central Nervous System Therapeutic Introduction
        11.1.4 Biogen Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.1.5 Biogen Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Central Nervous System Therapeutic Introduction
        11.2.4 Pfizer Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Teva
        11.3.1 Teva Company Detail
        11.3.2 Teva Business Overview
        11.3.3 Teva Central Nervous System Therapeutic Introduction
        11.3.4 Teva Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.3.5 Teva Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Central Nervous System Therapeutic Introduction
        11.4.4 Novartis Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Detail
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Central Nervous System Therapeutic Introduction
        11.5.4 Johnson & Johnson Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Development
    11.6 EliLilly
        11.6.1 EliLilly Company Detail
        11.6.2 EliLilly Business Overview
        11.6.3 EliLilly Central Nervous System Therapeutic Introduction
        11.6.4 EliLilly Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.6.5 EliLilly Recent Development
    11.7 Otsuka
        11.7.1 Otsuka Company Detail
        11.7.2 Otsuka Business Overview
        11.7.3 Otsuka Central Nervous System Therapeutic Introduction
        11.7.4 Otsuka Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.7.5 Otsuka Recent Development
    11.8 Merck
        11.8.1 Merck Company Detail
        11.8.2 Merck Business Overview
        11.8.3 Merck Central Nervous System Therapeutic Introduction
        11.8.4 Merck Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.8.5 Merck Recent Development
    11.9 AstraZeneca
        11.9.1 AstraZeneca Company Detail
        11.9.2 AstraZeneca Business Overview
        11.9.3 AstraZeneca Central Nervous System Therapeutic Introduction
        11.9.4 AstraZeneca Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.9.5 AstraZeneca Recent Development
    11.10 Novartis
        11.10.1 Novartis Company Detail
        11.10.2 Novartis Business Overview
        11.10.3 Novartis Central Nervous System Therapeutic Introduction
        11.10.4 Novartis Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.10.5 Novartis Recent Development
    11.11 Takeda
        11.11.1 Takeda Company Detail
        11.11.2 Takeda Business Overview
        11.11.3 Takeda Central Nervous System Therapeutic Introduction
        11.11.4 Takeda Revenue in Central Nervous System Therapeutic Business (2017-2022)
        11.11.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Central Nervous System Therapeutic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of OTC
    Table 3. Key Players of Rx Drugs
    Table 4. Global Central Nervous System Therapeutic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Central Nervous System Therapeutic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Central Nervous System Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Central Nervous System Therapeutic Market Share by Region (2017-2022)
    Table 8. Global Central Nervous System Therapeutic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Central Nervous System Therapeutic Market Share by Region (2023-2028)
    Table 10. Central Nervous System Therapeutic Market Trends
    Table 11. Central Nervous System Therapeutic Market Drivers
    Table 12. Central Nervous System Therapeutic Market Challenges
    Table 13. Central Nervous System Therapeutic Market Restraints
    Table 14. Global Central Nervous System Therapeutic Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Central Nervous System Therapeutic Market Share by Players (2017-2022)
    Table 16. Global Top Central Nervous System Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Therapeutic as of 2021)
    Table 17. Ranking of Global Top Central Nervous System Therapeutic Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Central Nervous System Therapeutic Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Central Nervous System Therapeutic Product Solution and Service
    Table 21. Date of Enter into Central Nervous System Therapeutic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Central Nervous System Therapeutic Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Central Nervous System Therapeutic Revenue Market Share by Type (2017-2022)
    Table 25. Global Central Nervous System Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Central Nervous System Therapeutic Revenue Market Share by Type (2023-2028)
    Table 27. Global Central Nervous System Therapeutic Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Central Nervous System Therapeutic Revenue Market Share by Application (2017-2022)
    Table 29. Global Central Nervous System Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Central Nervous System Therapeutic Revenue Market Share by Application (2023-2028)
    Table 31. North America Central Nervous System Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Central Nervous System Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Central Nervous System Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Central Nervous System Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Central Nervous System Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Central Nervous System Therapeutic Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Central Nervous System Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Central Nervous System Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Central Nervous System Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Central Nervous System Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Biogen Company Detail
    Table 42. Biogen Business Overview
    Table 43. Biogen Central Nervous System Therapeutic Product
    Table 44. Biogen Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 45. Biogen Recent Development
    Table 46. Pfizer Company Detail
    Table 47. Pfizer Business Overview
    Table 48. Pfizer Central Nervous System Therapeutic Product
    Table 49. Pfizer Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 50. Pfizer Recent Development
    Table 51. Teva Company Detail
    Table 52. Teva Business Overview
    Table 53. Teva Central Nervous System Therapeutic Product
    Table 54. Teva Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 55. Teva Recent Development
    Table 56. Novartis Company Detail
    Table 57. Novartis Business Overview
    Table 58. Novartis Central Nervous System Therapeutic Product
    Table 59. Novartis Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 60. Novartis Recent Development
    Table 61. Johnson & Johnson Company Detail
    Table 62. Johnson & Johnson Business Overview
    Table 63. Johnson & Johnson Central Nervous System Therapeutic Product
    Table 64. Johnson & Johnson Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 65. Johnson & Johnson Recent Development
    Table 66. EliLilly Company Detail
    Table 67. EliLilly Business Overview
    Table 68. EliLilly Central Nervous System Therapeutic Product
    Table 69. EliLilly Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 70. EliLilly Recent Development
    Table 71. Otsuka Company Detail
    Table 72. Otsuka Business Overview
    Table 73. Otsuka Central Nervous System Therapeutic Product
    Table 74. Otsuka Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 75. Otsuka Recent Development
    Table 76. Merck Company Detail
    Table 77. Merck Business Overview
    Table 78. Merck Central Nervous System Therapeutic Product
    Table 79. Merck Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 80. Merck Recent Development
    Table 81. AstraZeneca Company Detail
    Table 82. AstraZeneca Business Overview
    Table 83. AstraZeneca Central Nervous System Therapeutic Product
    Table 84. AstraZeneca Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 85. AstraZeneca Recent Development
    Table 86. Novartis Company Detail
    Table 87. Novartis Business Overview
    Table 88. Novartis Central Nervous System Therapeutic Product
    Table 89. Novartis Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 90. Novartis Recent Development
    Table 91. Takeda Company Detail
    Table 92. Takeda Business Overview
    Table 93. Takeda Central Nervous System TherapeuticProduct
    Table 94. Takeda Revenue in Central Nervous System Therapeutic Business (2017-2022) & (US$ Million)
    Table 95. Takeda Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Central Nervous System Therapeutic Market Share by Type: 2021 VS 2028
    Figure 2. OTC Features
    Figure 3. Rx Drugs Features
    Figure 4. Global Central Nervous System Therapeutic Market Share by Application in 2021 & 2028
    Figure 5. Hospital Case Studies
    Figure 6. Retail Pharmacy Case Studies
    Figure 7. Central Nervous System Therapeutic Report Years Considered
    Figure 8. Global Central Nervous System Therapeutic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Central Nervous System Therapeutic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Central Nervous System Therapeutic Market Share by Region: 2021 VS 2028
    Figure 11. Global Central Nervous System Therapeutic Market Share by Players in 2021
    Figure 12. Global Top Central Nervous System Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Therapeutic as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Central Nervous System Therapeutic Revenue in 2021
    Figure 14. North America Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Central Nervous System Therapeutic Market Share by Country (2017-2028)
    Figure 16. United States Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Central Nervous System Therapeutic Market Share by Country (2017-2028)
    Figure 20. Germany Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Central Nervous System Therapeutic Market Share by Region (2017-2028)
    Figure 28. China Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Central Nervous System Therapeutic Market Share by Country (2017-2028)
    Figure 36. Mexico Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Central Nervous System Therapeutic Market Share by Country (2017-2028)
    Figure 40. Turkey Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Central Nervous System Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Biogen Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 43. Pfizer Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 44. Teva Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 45. Novartis Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 46. Johnson & Johnson Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 47. EliLilly Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 48. Otsuka Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 49. Merck Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 50. AstraZeneca Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 51. Novartis Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 52. Takeda Revenue Growth Rate in Central Nervous System Therapeutic Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
EliLilly
Otsuka
Merck
AstraZeneca
Novartis
Takeda
Frequently Asked Questions
Central Nervous System Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Central Nervous System Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Central Nervous System Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ophthalmology Drugs

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More